FDA clears 2nd at-home Covid remedy, from Merck

FDA clears 2nd at-home Covid treatment, from Merck

The FDA’s authorization of Merck’s oral antiviral drug molnupiravir comes despite the agency’s advisory committee expressing concerns about the safety and efficacy of the drug.